Last reviewed · How we verify
NCT06605469
Ejaculatory and Orgasmic Dysfunction Registry
trial in Ejaculatory Dysfunction in 500 participants. Currently enrolling.
31 May 2029
Quick facts
| Lead sponsor | Charitable Union for the Research and Education of Peyronie's Disease |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 30 May 2024 |
| Primary completion | 31 May 2029 |
| Estimated completion | 31 May 2029 |
| Sites | 1 location across United States |
Conditions studied
- Ejaculatory Dysfunction — all drugs for Ejaculatory Dysfunction →
- Premature Ejaculation — all drugs for Premature Ejaculation →
- Delayed Ejaculation — all drugs for Delayed Ejaculation →
- Anorgasmia — all drugs for Anorgasmia →
Sponsor
Charitable Union for the Research and Education of Peyronie's Disease — full company profile →
Who can join
18 and older, any sex, with Ejaculatory Dysfunction or Premature Ejaculation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to evaluate the safety and efficacy of various therapies used to treat ejaculatory and/or orgasmic dysfunctions in men. The objective is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic dysfunction. Participants will submit questionnaires about their diagnosis and treatment efficacy and multiple time intervals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06605469
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Charitable Union for the Research and Education of Peyronie's Disease trials
Trials by the same sponsor.
- NCT05244486 — Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy · NA · recruiting
- NCT05108558 — Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders · Phase 4 · active not recruiting
- NCT04786106 — Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's · Phase 4 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06605469 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Charitable Union for the Research and Education of Peyronie's Disease
- Last refreshed: 14 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06605469.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing